Sirolimus-tacrolimus combination immunosuppression

Vivian C. McAlister; Zuhua Gao; Kevork Peltekian; Javier Domingues; Kamrar Mahalati; Allan S. MacDonald

doi:10.1016/S0140-6736(99)03882-9

Sirolimus-tacrolimus combination immunosuppression

Vivian C. McAlister, Zuhua Gao, Kevork Peltekian, Javier Domingues, Kamrar Mahalati, Allan S. MacDonald

Résultat de recherche: Article › examen par les pairs

298 Citations (Scopus)

Résumé

A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.

Langue d'origine	English
Pages (de-à)	376-377
Nombre de pages	2
Journal	The Lancet
Volume	355
Numéro de publication	9201
DOI	https://doi.org/10.1016/S0140-6736(99)03882-9
Statut de publication	Published - janv. 29 2000
Publié à l'externe	Oui

ASJC Scopus Subject Areas

General Medicine

PubMed: MeSH publication types

Clinical Trial
Letter

Accès au document

10.1016/S0140-6736(99)03882-9

Autres fichiers et liens

Citer

@article{df44e1335d1840889fb7f727c0abe45d,

title = "Sirolimus-tacrolimus combination immunosuppression",

abstract = "A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.",

author = "McAlister, {Vivian C.} and Zuhua Gao and Kevork Peltekian and Javier Domingues and Kamrar Mahalati and MacDonald, {Allan S.}",

year = "2000",

month = jan,

day = "29",

doi = "10.1016/S0140-6736(99)03882-9",

language = "English",

volume = "355",

pages = "376--377",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9201",

}

TY - JOUR

T1 - Sirolimus-tacrolimus combination immunosuppression

AU - McAlister, Vivian C.

AU - Gao, Zuhua

AU - Peltekian, Kevork

AU - Domingues, Javier

AU - Mahalati, Kamrar

AU - MacDonald, Allan S.

PY - 2000/1/29

Y1 - 2000/1/29

N2 - A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.

AB - A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.

UR - http://www.scopus.com/inward/record.url?scp=0034728055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034728055&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(99)03882-9

DO - 10.1016/S0140-6736(99)03882-9

M3 - Article

C2 - 10665560

AN - SCOPUS:0034728055

SN - 0140-6736

VL - 355

SP - 376

EP - 377

JO - The Lancet

JF - The Lancet

IS - 9201

ER -

Sirolimus-tacrolimus combination immunosuppression

Résumé

ASJC Scopus Subject Areas

PubMed: MeSH publication types

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer